Bank Of America Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $43.9 Million - $46.1 Million	302,714 Added 241.94%	427,832 $64.7 Million
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $15.6 Million - $27.5 Million	-188,157 Reduced 60.06%	125,118 $18.2 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $4.17 Million - $5.42 Million	37,914 Added 13.77%	313,275 $37.1 Million
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $3.07 Million - $4.58 Million	30,824 Added 12.61%	275,361 $37.9 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $608,817 - $855,546	6,159 Added 2.58%	244,537 $34 Million
Q2 2021 Sep 13, 2021	BUY	$65.78 - $105.02 $15.7 Million - $25 Million	238,378 New	238,378 $23.1 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.